Latest Breaking News On - Julie gralow - Page 13 : comparemela.com

Cancer patients push back against drugs harsh side effects

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.

United statesMount whitneyTimothy yapJulie gralowAlice shawJill feldmanChanapa tantibanchachaiLesley kailani glennLillian siuPatricia lorussoAmerican society of clinical oncologyDrug administrationMd anderson cancer centerPatient centered dosing initiativeYale cancer centerPrincess margaret cancer center

Cancer patients push back against drugs harsh side effects

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.

United statesMount whitneyLillian siuJulie gralowAlice shawChanapa tantibanchachaiLesley kailani glennPatricia lorussoTimothy yapJill feldmanPrincess margaret cancer centerYale cancer centerAmerican society of clinical oncologyDrug administrationMd anderson cancer centerPatient centered dosing initiative

Cancer patients push back against drugs harsh side effects

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.

United statesMount whitneyTimothy yapJulie gralowLesley kailani glennPatricia lorussoChanapa tantibanchachaiJill feldmanAlice shawLillian siuMd anderson cancer centerPatient centered dosing initiativeAmerican society of clinical oncologyYale cancer centerPrincess margaret cancer centerDrug administration

As cancer drug shortages persist, ASCO official urges congressional action at hearing

As cancer drug shortages persist, ASCO official urges congressional action at hearing
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesJulie gralowAmerican society of clinical oncologistsAmerican societyClinical oncologists

Drug shortage can put patients lives at risk, experts warn

Drug shortage can put patients lives at risk, experts warn
koka.am - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koka.am Daily Mail and Mail on Sunday newspapers.

United statesDavid schweikertJeromie ballreichSstephen schleicherStephen schondelmeyerBrad wenstrupJulie gralowUniversity of minnesota college pharmacyMeans committeeAmerican society of healthJohns hopkins bloomberg school of public healthAmerican society of clinical oncologyHouse waysSenate homeland security committeeAmerican societyTennessee oncology chief medical officer